Increased major histocompatibility complex (MHC)-I expression after irradiation has been detected in lung cancer, which may lead to enhanced antigen presentation to immune effector cells such as dendritic cells or CD8+ T-lymphocytes [29–31]. The gene discussed is CD8A; the disease is lung cancer.